Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NERV compared with FBRX: revenue, margins and what each company keeps, and the suppliers and customers both name
NERV
Minerva Neurosciences, Inc.
Change
Mkt cap
Revenue
Revenue
FBRX
Forte Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NERV
Minerva Neurosciences, Inc.
vs
FBRX
Forte Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
NERV
Minerva Neurosciences, Inc.
Change
2.38
▲
+1.59%
Mkt cap
$112.0M
FBRX
Forte Biosciences, Inc.
Change
77.01
▲
+0.05%
Regular session
Nov 3 '26
Mkt cap
$1.6B
vs
Compare
Regular session
Nov 3 '26
NERV
Minerva Neurosciences, Inc.
vs
FBRX
Forte Biosciences, Inc.
2.38
▲
+1.59%
Price
77.01
▲
+0.05%
$112.0M
Mkt cap
$1.6B
Change
Change
NERV
2.38
▲
+1.59%
vs
FBRX
77.01
▲
+0.05%
Regular session
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
NERV: latest quarter not drawable. FBRX: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NERV, solid
FBRX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NERV
7
RPRX
Royalty Pharma plc ("Royalty Pharma")
customer
—
Catalent
unlisted
supplier
—
Catalent Germany Schorndorf GmbH
unlisted
supplier
—
Dr. Inderjit Kaul
unlisted
supplier
3 more · NERV chain
›
Shared
0
No disclosed counterparties: FBRX.
Only FBRX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR